Home › Funds › QV Investors Inc. › SOLV
QV Investors Inc. position in SOLV
SOLVENTUM CORP · Health Care
QV Investors Inc. reported holding 154,502 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$13.6M, representing 1.00% of its reported portfolio and ranking #32 among its reported holdings. QV Investors Inc. has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How QV Investors Inc.'s SOLV position evolved
QV Investors Inc. first disclosed a stake in SOLV in Q2 2024 at 157,192 shares (US$8.3M). The position peaked in Q4 2025 at 239,252 shares, worth US$19.0M. Across 10 filings, QV Investors Inc. increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 154,502 shares valued at US$13.6M — a reduction of -64,190 shares quarter over quarter.. Notable position changes include a 59% increase in Q3 2024 (shares fell 5% over the following quarter), a 27% trim in Q4 2024 (shares rose 15% over the following quarter), a 29% trim in Q3 2026 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 157.19K | $8.31M | New |
| Q3 2024 | 250.56K | $17.47M | Add |
| Q4 2024 | 182.31K | $12.04M | Reduce |
| Q1 2025 | 209.79K | $15.95M | Add |
| Q2 2025 | 204.39K | $15.50M | Reduce |
| Q3 2025 | 235.08K | $17.16M | Add |
| Q4 2025 | 239.25K | $18.96M | Add |
| Q1 2026 | 224.67K | $14.67M | Reduce |
| Q2 2026 | 218.69K | $16.87M | Reduce |
| Q3 2026 | 154.50K | $13.62M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SOLV and 13F data
SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SOLV
- Independent Franchise Partners LLP 15.67M sh · $1.38B · Q3 2026
- TRIAN FUND MANAGEMENT, L.P. 8.24M sh · $635.47M · Q2 2026
- DAVIS SELECTED ADVISERS 6.41M sh · $565.42M · Q3 2026
- Diamond Hill Capital Management, LLC (Investment Advisor) 1.58M sh · $139.38M · Q3 2026
- Madison Avenue Partners, LP 1.74M sh · $134.34M · Q2 2026
- EQUITY INVESTMENT CORP 867.55K sh · $76.47M · Q3 2026
- ANCHOR CAPITAL ADVISORS LLC 533.38K sh · $47.02M · Q3 2026
More on QV Investors Inc.
FAQ
How long has QV Investors Inc. held SOLV?
QV Investors Inc. has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is QV Investors Inc.'s current position in SOLV?
As of Q3 2026, QV Investors Inc. holds 154.50K shares of SOLV (SOLVENTUM CORP), valued at $13.62M, representing 1.00% of its reported portfolio and ranking #32.
Has QV Investors Inc. been buying or selling SOLV?
In the latest 13F filing (Q3 2026), QV Investors Inc. reduced its position in SOLV. The position peaked in Q4 2025 at 239.25K shares.
Which other funds hold SOLV?
Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.